Cannabis News Box

Cannabis study: Whole-plant cannabis is more powerful at treating epilepsy than CBD

Cannabis study: Whole-plant cannabis is more powerful at treating epilepsy than CBD

Brazilian researchers say that "CBD-rich extracts seem to present a better therapeutic profile than purified CBD"
Bethan Rose Jenkins, Cannabis News Writer/Editorial October 5, 2018

The number of cannabis studies demonstrating the plant’s medical potency for the treatment of epilepsy, among many other ailments, is rapidly increasing.  In June, the Food and Drug Administration...

https://www.weednews.co/gw-pharmaceuticals-announces-acceptance-of-nda-filing-for-epidiolex/

Cannabis-based epilepsy treatment Epidiolex will cost $32,500 annually

The expensive price tag means that the parents of children with Lennox syndrome and Dravet syndrome may search for cheaper CBD-based treatments elsewhere
Bethan Rose Jenkins, Cannabis News Writer/Editorial August 29, 2018

Epilepsy sufferers may never have to worry about enduring bouts of life-threatening seizures ever again, thanks to the Food and Drug Administration (FDA) approving the world’s first ever cannabis-derived...

https://www.vice.com/en_uk/article/pp4e9b/this-is-how-much-the-uk-would-actually-make-if-it-taxed-cannabis

Great Britain prepares to legalize cannabis for medicinal use

The Advisory Council on the Misuse of Drugs (ACMD) wants doctors to prescribe medicinal cannabis medicines that have been developed in accordance with safety standards.
Bethan Rose Jenkins, Cannabis News Writer/Editorial August 3, 2018

Medical cannabis is set to become available on prescription in the UK after the government approved a law to permit medicines derived from the cannabis plant. According to the Home Office, cannabis-based...

https://globenewswire.com/news-release/2018/06/25/1529165/0/en/GW-Pharmaceuticals-plc-and-its-U-S-Subsidiary-Greenwich-Biosciences-Announce-FDA-Approval-of-EPIDIOLEX-cannabidiol-oral-solution-the-First-Plant-derived-Cannabinoid-Prescription-Me.html

CEO of GW Pharma talks about Epidiolex getting FDA approval

The DEA must accurately categorize CBD within 90 days of the approval
Bethan Rose Jenkins, Cannabis News Writer/Editorial July 2, 2018

On Monday, Justin Gover hit a milestone in his career. He is the CEO of GW Pharmaceuticals – a company that created a cannabis-based medicine called Epidiolex. Not only is Epidiolex being used to treat...

https://www.weednews.co/gw-pharmaceuticals-announces-acceptance-of-nda-filing-for-epidiolex/

Will Epidiolex be the first cannabis-based drug to be approved as an epilepsy treatment?

Bethan Rose Jenkins, Cannabis News Writer/Editorial May 3, 2018

A cannabis-based medication for epilepsy could be the first to gain approval by the Food and Drug Administration (FDA). Created by British company GW Pharmaceuticals, cannabis-based epilepsy treatment...

https://www.medicaljane.com/2014/07/02/preliminary-study-cannabis-based-drug-may-help-battle-treatment-resistant-epilepsy/

FDA gives positive review for GW Pharmaceuticals’ cannabis-based medicine Epidiolex

Bethan Rose Jenkins, Cannabis News Writer/Editorial April 19, 2018

Epidiolex, a cannabis-based treatment for epilepsy from GW Pharmaceuticals, received a positive review from staff at the Federal Drug Administration (FDA) on Tuesday. GW Pharmaceuticals provided “substantial...

Load More Stories
Activate Search
GW Pharmaceuticals